Cassava Sciences, Inc. (SAVA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Cassava's strong liquidity with $128.6 million in cash supports early-stage development, yet long-term funding needs may lead ...

Cassava Sciences ( ($SAVA) ) has released its Q4 earnings. Here is a breakdown of the information Cassava Sciences presented to its investors.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. For many shoppers, Amazon Prime is a no-brainer for the shipping perks alone. However ...

Cassava Sciences (SAVA) has entered into an agreement with Yale University for a license to intellectual property rights, including an exclusive license to an issued US method of treatment patent ...

AUSTIN, Texas, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company ...

AUSTIN, Texas, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel ...

The Federal Government has pledged its support for Agbeyewa Farms investment in cassava farming and agro-processing, describing the initiative as a model for achieving food security and economic ...